Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy

Summary

The present study will assess the low-density lipoprotein cholesterol (LDL-C) lowering effect of colesevelam as an adjunct to niacin for the improvement of lipids and glycemic control in dyslipidemic subjects with impaired fasting glucose.

Timeline

Start

2010-11

Primary completion

2011-08

Completion

2011-08

Drugs

Indications